- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01492348
Stepped Enhancement of PTSD Services Using Primary Care (STEPS UP): A Randomized Effectiveness Trial (STEPS UP)
The overall objective of this study is to test the effectiveness of a systems-level approach to primary care recognition and management of PTSD and depression in the military health system. More specifically, the investigators will test the effectiveness of a telephone care management with preference-based stepped PTSD/depression care--STepped Enhancement of PTSD Services Using Primary Care (STEPS UP)--as compared to Optimized Usual Care (OUC).
Primary Hypothesis 1: Active duty primary care patients with PTSD, depression, or both who are randomly assigned to STEPS UP will report significantly greater reductions in PTSD and depression symptom severity compared to participants assigned to OUC over 12-months of follow-up.
Hypothesis 2: Active duty primary care patients with either PTSD, depression, or both who are randomly assigned to STEPS UP will report significantly greater improvements in somatic symptom severity, alcohol use, mental health functioning, and work functioning compared to participants assigned to OUC over 12-months of follow-up.
Hypothesis 3: The STEPS UP program will be both more costly and more effective compared to OUC over the 12-months of follow-up, and will have a favorable cost-effectiveness ratio in terms of dollars per quality adjusted life years saved.
Hypothesis 4: Active duty primary care patients participating in STEPS UP, their clinicians, care managers, and family members will report that STEPS UP is acceptable, effective, satisfying, and appropriate PTSD and depression care.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Despite the significant prevalence of posttraumatic stress disorder (PTSD) and depression among veterans returning from Operations in Iraq and Afghanistan, less than half of service members who are referred for a specialty mental health assessment actually receive specialty mental health treatment. Systematic knowledge regarding access to care and quality of care delivered in civilian, VA, and military facilities for those who encounter barriers or difficulty is scant, and recent policy reviews have strongly questioned availability and quality of care. These problems of access and quality are major, overarching problems in war-related PTSD research. There are scientifically tested strategies from non-military settings and for other mental disorders to improve access to and quality of care; unfortunately, these strategies are unstudied in the military health system and for PTSD and depression. These strategies include care manager coordination (connecting patient, provider, and specialist), collaborative care (negotiated patient-provider problem definition, monitoring of status and treatment response, self-management support, telehealth sustained follow-up), and stepped care (logical, patient-centered and guideline-concordant treatment sequencing). This study aims to fill these gaps and evaluate these systems-level strategies in a military setting for PTSD and depression.
The purpose of the STEPS UP (STepped Enhancement of PTSD Services Using Primary Care) trial is to compare centralized telephonic care management with preference-based stepped PTSD and depression care to optimized usual care. We hypothesize that the STEPS UP intervention will lead to improvements in (1) PTSD and depression symptom severity (primary hypothesis); (2) somatic symptom severity, alcohol use, mental health functioning, work functioning; (3) costs and cost-effectiveness. We further hypothesize that qualitative data obtained from interviews will show that (4) patients, their family members, and participating clinicians find the STEPS-UP intervention to be an acceptable, effective, and satisfying approach to deliver and receive PTSD and depression care.
STEPS-UP is a six-site, two-parallel arm (N = 666) randomized controlled effectiveness trial with 3-month, 6-month, and 12-month follow-up comparing centralized telephonic stepped-care management to optimized usual PTSD and depression care. In addition to the existing PTSD and depression treatment options, STEPS UP includes web-based cognitive behavioral self-management, telephone cognitive-behavioral therapy, continuous RN nurse care management, and computer-automated care management support. Both arms can refer patients for mental health specialty care as needed, preferred and available. The study uses sites currently running RESPECT-Mil, the existing military primary care-mental health services practice network, to access site health care leaders and potential study participants at the 6 study sites.
If effective, we expect that STEPS UP will increase the percentage of military personnel with unmet PTSD- and depression-related health care needs who get timely, effective, and efficient PTSD and depression care. Our real-world primary care effectiveness emphasis will prevent the Institute of Medicine's so called "15 year science to service gap." If successful, STEPS UP could roll out immediately, reinforcing and facilitating pathways to PTSD and depression recovery.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Colorado
-
Ft. Carson, Colorado, United States, 80913
- Evans Army Community Hospital
-
-
Georgia
-
Fort Stewart, Georgia, United States, 31409-5102
- Winn Army Community Hospital
-
-
Kentucky
-
Fort Campbell, Kentucky, United States, 42333
- Blanchfield Army Community Hospital
-
-
North Carolina
-
Ft. Bragg, North Carolina, United States, 28310
- Womack Army Medical Center
-
-
Texas
-
Fort Bliss, Texas, United States, 79920-5001
- William Beaumont Army Medical Center
-
-
Washington
-
Tacoma, Washington, United States, 98431
- Madigan Army Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Active duty status at the time of enrollment
- Positive PTSD screen (2 or more yes responses on PC-PTSD), per routine primary care screening.
- DSM-IV-TR criteria for A) PTSD using the PCL-C (i.e.., a "moderate" or greater severity level on 1 re-experiencing, 3 avoidance, and 2 hyperarousal symptoms) and/or B) Depression, using the PHQ-9 (i.e., endorsement of at least 5 of the 9 symptoms experienced "more than half the days" and at least one of those symptoms must include either "little interest or pleasure in doing things" or "feeling down, depressed or hopeless")
- Report of routine computer, Internet, and e-mail access
- Capacity to consent to participation and provide research informed consent using local IRB-approved form
Exclusion Criteria:
- Treatment refractory PTSD or depression after participation in RESPECT-mil or specialty mental health treatment.
- Acute psychosis, psychotic episode, or psychotic disorder diagnosis by history within the past 2 years
- Bipolar I disorder by history or medical record review within last 2 years.
- Active substance dependence disorder in the past year by history within the past 12 months.
- Active suicidal ideation within the past 2 months by history.
- Patients on psychoactive medication, unless that medication dosing and administration has been stable and regular for at least 1 month.
- Acute or unstable physical illness.
- Anticipated deployment, demobilization, or separation during the next six months.
- Personnel who work in participating clinics.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: STEPS UP Intervention
STEPS UP is a centrally assisted stepped collaborative telecare management program within primary care.
The STEPS UP intervention added to Optimized Usual Care (PCMH-BH; formerly RESPECT-Mil) in 4 ways: (1) care management enhancements; (2) stepped psychosocial treatment options (web, phone, in person); (3) electronic symptom registry for measurement-based treatment planning (symptoms are measured at regular intervals and care is intensified for patients with recurrent or persistent PTSD and/or depressive) and for telecare manager caseload and site performance monitoring; and (4) routine assisted review of patient, telecare manager, and site performance by a central psychiatrist and psychologist.
|
The STEPS UP intervention enhances RESPECT-Mil in several ways:
|
Active Comparator: Optimized Usual Care (OUC)
Service members randomized to Optimized Usual Care (OUC) will get usual treatment at the site.
OUC is RESPECT-Mil, a voluntary, primary care-based implementation program where, with the assistance and collaboration of a psychiatrist and an on-site nurse-level care manager, service members with symptoms of PTSD and depression are screened, tracked, and treated within the primary care system.
|
Service members randomized to Optimized Usual Care (OUC) will get usual treatment at the site.
OUC is RESPECT-Mil, a voluntary, primary care-based implementation program based on the "three-component model" where, with the assistance and collaboration of a psychiatrist and an on-site nurse-level care manager, service members with symptoms of PTSD and depression are screened, tracked, and treated within the primary care system.
Components of the RESPECT-Mil program include (1) equipping and training primary care clinics to screen each visit and use symptom severity tools for diagnosis and assessment; (2) using nurse care managers to assist patients and primary care clinicians; and (3) increasing access to a mental health specialist, often using a clinic specialist.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Posttraumatic Diagnostic Scale (PDS)
Time Frame: baseline - 3 months
|
The PDS (Foa, 1996) is a 49-item self-report measure that assesses both severity of PTSD symptoms related to a single identified traumatic event and probable diagnosis of PTSD.
|
baseline - 3 months
|
Posttraumatic Diagnostic Scale (PDS)
Time Frame: baseline - 6 months
|
The PDS (Foa, 1996) is a 49-item self-report measure that assesses both severity of PTSD symptoms related to a single identified traumatic event and probable diagnosis of PTSD.
|
baseline - 6 months
|
Posttraumatic Diagnostic Scale (PDS)
Time Frame: baseline - 12 months
|
The PDS (Foa, 1996) is a 49-item self-report measure that assesses both severity of PTSD symptoms related to a single identified traumatic event and probable diagnosis of PTSD.
|
baseline - 12 months
|
Hopkins Symptom Checklist Depression Scale-20 Item Version (HSCL-20)
Time Frame: baseline - 3 months
|
The HSCL-20 is a self-report scale comprising the 13 items of the Hopkins Symptom Checklist Depression Scale plus 7 additional items from the Hopkins Symptom Checklist-90-Revised.
The HSCL-20 has been widely used as an outcome measure of depressive severity in large clinical trials (Boudreau, et al., 2002; Felker, et al., 2001; Fraser, et al., 2004; Hedrick, et al., 2003; Katon, et al., 1996; Kroenke, et al., 2001; Unutzer, et al., 2002; Williams, et al., 2000).
|
baseline - 3 months
|
Hopkins Symptom Checklist Depression Scale-20 Item Version (HSCL-20)
Time Frame: baseline - 6 months
|
The HSCL-20 is a self-report scale comprising the 13 items of the Hopkins Symptom Checklist Depression Scale plus 7 additional items from the Hopkins Symptom Checklist-90-Revised.
The HSCL-20 has been widely used as an outcome measure of depressive severity in large clinical trials (Boudreau, et al., 2002; Felker, et al., 2001; Fraser, et al., 2004; Hedrick, et al., 2003; Katon, et al., 1996; Kroenke, et al., 2001; Unutzer, et al., 2002; Williams, et al., 2000).
|
baseline - 6 months
|
Hopkins Symptom Checklist Depression Scale-20 Item Version (HSCL-20)
Time Frame: baseline - 12 months
|
The HSCL-20 is a self-report scale comprising the 13 items of the Hopkins Symptom Checklist Depression Scale plus 7 additional items from the Hopkins Symptom Checklist-90-Revised.
The HSCL-20 has been widely used as an outcome measure of depressive severity in large clinical trials (Boudreau, et al., 2002; Felker, et al., 2001; Fraser, et al., 2004; Hedrick, et al., 2003; Katon, et al., 1996; Kroenke, et al., 2001; Unutzer, et al., 2002; Williams, et al., 2000).
|
baseline - 12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Somatic Symptom Severity - Patient Health Questionnaire - 15 (PHQ-15)
Time Frame: baseline - 3 months
|
Somatic symptom severity will be measured with the widely used and validated 15 item Patient Health Questionnaire (PHQ-15; Kroenke, Spitzer, & Williams, 2002).
A total sum of greater than or equal to 15 indicate a high somatic symptom severity based on data from primary care settings (Kroenke et al., 2002).
|
baseline - 3 months
|
Somatic Symptom Severity - Patient Health Questionnaire - 15 (PHQ-15)
Time Frame: baseline - 6 months
|
Somatic symptom severity will be measured with the widely used and validated 15 item Patient Health Questionnaire (PHQ-15; Kroenke, Spitzer, & Williams, 2002).
A total sum of greater than or equal to 15 indicate a high somatic symptom severity based on data from primary care settings (Kroenke et al., 2002).
|
baseline - 6 months
|
Somatic Symptom Severity - Patient Health Questionnaire - 15 (PHQ-15)
Time Frame: baseline - 12 months
|
Somatic symptom severity will be measured with the widely used and validated 15 item Patient Health Questionnaire (PHQ-15; Kroenke, Spitzer, & Williams, 2002).
A total sum of greater than or equal to 15 indicate a high somatic symptom severity based on data from primary care settings (Kroenke et al., 2002).
|
baseline - 12 months
|
Alcohol Use Disorders Identification Test (AUDIT)
Time Frame: eligibility - 3 months
|
The AUDIT (Babor, Higgins-Biddle, Saunders, & Monteiro, 2001) will be used to assess alcohol use, alcohol dependence symptoms, and alcohol-related problems, focused on the recent past.
This 10-item scale is widely used and has been shown to be consistent with ICD-10 definitions for alcohol dependence and harmful alcohol use (Allen, Litten, Fertig, & Babor, 1997; Saunders, Aasland, Amundsen, & Grant, 1993; Saunders, Aasland, Babor, de, & Grant, 1993)
|
eligibility - 3 months
|
Alcohol Use Disorders Identification Test (AUDIT)
Time Frame: eligibility - 6 months
|
The AUDIT (Babor, Higgins-Biddle, Saunders, & Monteiro, 2001) will be used to assess alcohol use, alcohol dependence symptoms, and alcohol-related problems, focused on the recent past.
This 10-item scale is widely used and has been shown to be consistent with ICD-10 definitions for alcohol dependence and harmful alcohol use (Allen, Litten, Fertig, & Babor, 1997; Saunders, Aasland, Amundsen, & Grant, 1993; Saunders, Aasland, Babor, de, & Grant, 1993)
|
eligibility - 6 months
|
Alcohol Use Disorders Identification Test (AUDIT)
Time Frame: eligibility - 12 months
|
The AUDIT (Babor, Higgins-Biddle, Saunders, & Monteiro, 2001) will be used to assess alcohol use, alcohol dependence symptoms, and alcohol-related problems, focused on the recent past.
This 10-item scale is widely used and has been shown to be consistent with ICD-10 definitions for alcohol dependence and harmful alcohol use (Allen, Litten, Fertig, & Babor, 1997; Saunders, Aasland, Amundsen, & Grant, 1993; Saunders, Aasland, Babor, de, & Grant, 1993)
|
eligibility - 12 months
|
Health-Related Quality of Life and Functional Status - Medical Outcomes Study Short Form-12 (SF-12)
Time Frame: baseline - 3 months
|
Limitations in role functioning will be assessed using the SF-12 (Ware et al., 1996).
The SF-12 is a widely used measure of health-related quality of life and functioning with established reliability and validity.
This measure will be used for the economic analysis as well as to measure functioning as an outcome.
|
baseline - 3 months
|
Health-Related Quality of Life and Functional Status - Medical Outcomes Study Short Form-12 (SF-12)
Time Frame: baseline - 6 months
|
Limitations in role functioning will be assessed using the SF-12 (Ware et al., 1996).
The SF-12 is a widely used measure of health-related quality of life and functioning with established reliability and validity.
This measure will be used for the economic analysis as well as to measure functioning as an outcome.
|
baseline - 6 months
|
Health-Related Quality of Life and Functional Status - Medical Outcomes Study Short Form-12 (SF-12)
Time Frame: baseline - 12 months
|
Limitations in role functioning will be assessed using the SF-12 (Ware et al., 1996).
The SF-12 is a widely used measure of health-related quality of life and functioning with established reliability and validity.
This measure will be used for the economic analysis as well as to measure functioning as an outcome.
|
baseline - 12 months
|
WHO Health and Work Performance Questionnaire-Short Form (HPQ-SF)
Time Frame: baseline - 3 months
|
The HPQ-SF (Kessler, et al., 2004; Kessler, et al., 2003) will be used to assess work presenteeism and absenteeism.
The self-report survey contains 11 items and assesses work in the prior 4 weeks.
These items will be used both to assess work functioning and to estimate costs related to PTSD and associated conditions.
|
baseline - 3 months
|
WHO Health and Work Performance Questionnaire-Short Form (HPQ-SF)
Time Frame: baseline - 6 months
|
The HPQ-SF (Kessler, et al., 2004; Kessler, et al., 2003) will be used to assess work presenteeism and absenteeism.
The self-report survey contains 11 items and assesses work in the prior 4 weeks.
These items will be used both to assess work functioning and to estimate costs related to PTSD and associated conditions.
|
baseline - 6 months
|
WHO Health and Work Performance Questionnaire-Short Form (HPQ-SF)
Time Frame: baseline - 12 months
|
The HPQ-SF (Kessler, et al., 2004; Kessler, et al., 2003) will be used to assess work presenteeism and absenteeism.
The self-report survey contains 11 items and assesses work in the prior 4 weeks.
These items will be used both to assess work functioning and to estimate costs related to PTSD and associated conditions.
|
baseline - 12 months
|
Numeric Rating Scale for Pain
Time Frame: baseline - 3 months
|
This trial will use a two-item numeric rating scale for pain, adapted from the NRS (Cleeland and Ryan, 1994) and the University of Washington's IMPACT studies.
The items ask patients to rate pain intensity on average and how much the pain interferes with their daily activities on 11-point numeric rating scales.
|
baseline - 3 months
|
Numeric Rating Scale for Pain
Time Frame: baseline - 6 months
|
This trial will use a two-item numeric rating scale for pain, adapted from the NRS (Cleeland and Ryan, 1994) and the University of Washington's IMPACT studies.
The items ask patients to rate pain intensity on average and how much the pain interferes with their daily activities on 11-point numeric rating scales.
|
baseline - 6 months
|
Numeric Rating Scale for Pain
Time Frame: baseline - 12 months
|
This trial will use a two-item numeric rating scale for pain, adapted from the NRS (Cleeland and Ryan, 1994) and the University of Washington's IMPACT studies.
The items ask patients to rate pain intensity on average and how much the pain interferes with their daily activities on 11-point numeric rating scales.
|
baseline - 12 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Robert M Bray, PhD, RTI International
- Principal Investigator: Lisa Jaycox, PhD, RAND
- Principal Investigator: Bradley E Belsher, PhD, United States Department of Defense
Publications and helpful links
General Publications
- Hoge CW, Castro CA, Messer SC, McGurk D, Cotting DI, Koffman RL. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Engl J Med. 2004 Jul 1;351(1):13-22. doi: 10.1056/NEJMoa040603.
- Hoge CW, Auchterlonie JL, Milliken CS. Mental health problems, use of mental health services, and attrition from military service after returning from deployment to Iraq or Afghanistan. JAMA. 2006 Mar 1;295(9):1023-32. doi: 10.1001/jama.295.9.1023.
- Litz BT, Engel CC, Bryant RA, Papa A. A randomized, controlled proof-of-concept trial of an Internet-based, therapist-assisted self-management treatment for posttraumatic stress disorder. Am J Psychiatry. 2007 Nov;164(11):1676-83. doi: 10.1176/appi.ajp.2007.06122057.
- Engel CC. Improving primary care for military personnel and veterans with posttraumatic stress disorder--the road ahead. Gen Hosp Psychiatry. 2005 May-Jun;27(3):158-60. doi: 10.1016/j.genhosppsych.2005.01.001. No abstract available.
- Engel CC, Hyams KC, Scott K. Managing future Gulf War Syndromes: international lessons and new models of care. Philos Trans R Soc Lond B Biol Sci. 2006 Apr 29;361(1468):707-20. doi: 10.1098/rstb.2006.1829.
- Spira, J.L., Pyne, J.M., & Wiederhold, B. (2006). Chapter 10: Experiential Methods in the Treatment of Combat PTSD. In Figley, C.R. and Nash, W.P. In For Those Who Bore the Battle: Combat Stress Injury Theory, Research, and Management. For the Routledge Psychosocial Stress Book Series
- Tanielian, T. & Jaycox, L., Eds. "Invisible Wounds of War: Psychological and Cognitive Injuries, Their Consequences, and Services to Assist Recovery." RAND/MG-720- CCF (available at http://veterans.rand.org)
- Jaycox LH, Stein BD, Kataoka SH, Wong M, Fink A, Escudero P, Zaragoza C. Violence exposure, posttraumatic stress disorder, and depressive symptoms among recent immigrant schoolchildren. J Am Acad Child Adolesc Psychiatry. 2002 Sep;41(9):1104-10. doi: 10.1097/00004583-200209000-00011.
- Lisa S. Meredith, Terri L. Tanielian, Michael D. Greenberg, Ana Suárez, Elizabeth Eiseman. "Expanding Access to Mental Health Counselors: Evaluation of the Tricare Demonstration" RAND/DRR-3458-1-OSD (available at www.rand.org)
- Stein BD, Tanielian TL, Ryan GW, Rhodes HJ, Young SD, Blanchard JC. A bitter pill to swallow: nonadherence with prophylactic antibiotics during the anthrax attacks and the role of private physicians. Biosecur Bioterror. 2004;2(3):175-85. doi: 10.1089/bsp.2004.2.175.
- Meredith LS, Mendel P, Pearson M, Wu SY, Joyce G, Straus JB, Ryan G, Keeler E, Unutzer J. Implementation and maintenance of quality improvement for treating depression in primary care. Psychiatr Serv. 2006 Jan;57(1):48-55. doi: 10.1176/appi.ps.57.1.48.
- Williams JW Jr, Gerrity M, Holsinger T, Dobscha S, Gaynes B, Dietrich A. Systematic review of multifaceted interventions to improve depression care. Gen Hosp Psychiatry. 2007 Mar-Apr;29(2):91-116. doi: 10.1016/j.genhosppsych.2006.12.003.
- Engel CC, Oxman T, Yamamoto C, Gould D, Barry S, Stewart P, Kroenke K, Williams JW Jr, Dietrich AJ. RESPECT-Mil: feasibility of a systems-level collaborative care approach to depression and post-traumatic stress disorder in military primary care. Mil Med. 2008 Oct;173(10):935-40. doi: 10.7205/milmed.173.10.935.
- Engel CC, Bray RM, Jaycox LH, Freed MC, Zatzick D, Lane ME, Brambilla D, Rae Olmsted K, Vandermaas-Peeler R, Litz B, Tanielian T, Belsher BE, Evatt DP, Novak LA, Unutzer J, Katon WJ. Implementing collaborative primary care for depression and posttraumatic stress disorder: design and sample for a randomized trial in the U.S. military health system. Contemp Clin Trials. 2014 Nov;39(2):310-9. doi: 10.1016/j.cct.2014.10.002. Epub 2014 Oct 12.
- Belsher BE, Jaycox LH, Freed MC, Evatt DP, Liu X, Novak LA, Zatzick D, Bray RM, Engel CC. Mental Health Utilization Patterns During a Stepped, Collaborative Care Effectiveness Trial for PTSD and Depression in the Military Health System. Med Care. 2016 Jul;54(7):706-13. doi: 10.1097/MLR.0000000000000545.
- Engel CC, Jaycox LH, Freed MC, Bray RM, Brambilla D, Zatzick D, Litz B, Tanielian T, Novak LA, Lane ME, Belsher BE, Olmsted KL, Evatt DP, Vandermaas-Peeler R, Unutzer J, Katon WJ. Centrally Assisted Collaborative Telecare for Posttraumatic Stress Disorder and Depression Among Military Personnel Attending Primary Care: A Randomized Clinical Trial. JAMA Intern Med. 2016 Jul 1;176(7):948-56. doi: 10.1001/jamainternmed.2016.2402.
- Tanielian T, Woldetsadik MA, Jaycox LH, Batka C, Moen S, Farmer C, Engel CC. Barriers to Engaging Service Members in Mental Health Care Within the U.S. Military Health System. Psychiatr Serv. 2016 Jul 1;67(7):718-27. doi: 10.1176/appi.ps.201500237. Epub 2016 Mar 15.
- Batka C, Tanielian T, Woldetsadik MA, Farmer C, Jaycox LH. Stakeholder Experiences in a Stepped Collaborative Care Study Within U.S. Army Clinics. Psychosomatics. 2016 Nov-Dec;57(6):586-597. doi: 10.1016/j.psym.2016.05.008. Epub 2016 May 31.
- Bray RM, Engel CC, Williams J, Jaycox LH, Lane ME, Morgan JK, Unutzer J. Posttraumatic Stress Disorder in U.S. Military Primary Care: Trajectories and Predictors of One-Year Prognosis. J Trauma Stress. 2016 Aug;29(4):340-8. doi: 10.1002/jts.22119. Epub 2016 Jul 22.
- Belsher BE, Evatt DP, Liu X, Freed MC, Engel CC, Beech EH, Jaycox LH. Collaborative Care for Depression and Posttraumatic Stress Disorder: Evaluation of Collaborative Care Fidelity on Symptom Trajectories and Outcomes. J Gen Intern Med. 2018 Jul;33(7):1124-1130. doi: 10.1007/s11606-018-4451-5. Epub 2018 Apr 27.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- W81XWH-09-2-0077
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on STEPS UP
-
University of Texas at AustinCompleted
-
Guangzhou General Hospital of Guangzhou Military...The First Affiliated Hospital of Guangzhou Medical University; Medical Center...CompletedOsteoarthritis | Osteoarthritis, KneeChina
-
The University of Tennessee, KnoxvilleNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes, GestationalUnited States
-
University of MichiganEmory University; Ann & Robert H Lurie Children's Hospital of Chicago; Harvard...Completed
-
Roswell Park Cancer InstituteCompletedPlasma Cell MyelomaUnited States
-
Virginia Polytechnic Institute and State UniversityUniversity of Alabama at BirminghamCompletedAutism Spectrum DisorderUnited States
-
University of Alabama, TuscaloosaRecruitingAutism Spectrum DisorderUnited States
-
Duke UniversityCompleted
-
Beth Israel Deaconess Medical CenterUniversity of Michigan; Brigham and Women's Hospital; VA Boston Healthcare SystemNot yet recruitingChronic Obstructive Pulmonary Disease | Chronic Heart FailureUnited States
-
Glostrup University Hospital, CopenhagenRigshospitalet, DenmarkActive, not recruitingChronic IllnessDenmark